Pacer Advisors Portfolio holdings
AUM
$39.6B
1-Year Return
5.04%
This Quarter Return
+6.36%
1 Year Return
+5.04%
3 Year Return
+42.86%
5 Year Return
+91.64%
10 Year Return
+332.32%
AUM
$5.75B
AUM Growth
+$430M
(+8.1%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-18.82%
Top 10 Holdings %
Top 10 Hldgs %
27.15%
Holding
1,587
New
76
Increased
379
Reduced
937
Closed
183
Top Buys
| 1 |
HP
HPQ
|
+$6.72M |
| 2 |
Newmont
NEM
|
+$6.32M |
| 3 |
General Mills
GIS
|
+$6.24M |
| 4 |
TJX Companies
TJX
|
+$5.82M |
| 5 |
Ford
F
|
+$5.76M |
Top Sells
| 1 |
Iron Mountain
IRM
|
+$16.2M |
| 2 |
Apple
AAPL
|
+$15.9M |
| 3 |
Amazon
AMZN
|
+$14.5M |
| 4 |
Microsoft
MSFT
|
+$13.1M |
| 5 |
GDS Holdings
GDS
|
+$7.93M |
Sector Composition
| 1 | Real Estate | 17.47% |
| 2 | Technology | 14.61% |
| 3 | Consumer Discretionary | 9.29% |
| 4 | Healthcare | 7.36% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Vale
VALE
$45.4B
| $82K | ﹤0.01% |
4,699
+1,766
| +60% | +$30.8K |
|
|
GTHX
1177
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $81K | ﹤0.01% |
3,366
-710
| -17% | -$17.1K |
|
|
DCPH
1178
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $81K | ﹤0.01% |
1,798
-428
| -19% | -$19.3K |
|
1179
United Microelectronic
UMC
$17B
| $80K | ﹤0.01% |
8,749
+3,586
| +69% | +$32.8K |
|
1180
Dynavax Technologies
DVAX
$1.14B
| $80K | ﹤0.01% |
8,133
-10,642
| -57% | -$105K |
|
1181
Exact Sciences
EXAS
$10.6B
| $80K | ﹤0.01% |
604
-415
| -41% | -$55K |
|
1182
Veracyte
VCYT
$2.51B
| $80K | ﹤0.01% |
1,488
-720
| -33% | -$38.7K |
|
1183
CareDx
CDNA
$724M
| $79K | ﹤0.01% |
1,154
-758
| -40% | -$51.9K |
|
1184
Cytokinetics
CYTK
$6.37B
| $79K | ﹤0.01% |
3,417
-2,214
| -39% | -$51.2K |
|
1185
Agios Pharmaceuticals
AGIO
$2.12B
| $78K | ﹤0.01% |
1,504
-2,420
| -62% | -$126K |
|
1186
Alnylam Pharmaceuticals
ALNY
$61.4B
| $78K | ﹤0.01% |
550
-472
| -46% | -$66.9K |
|
1187
Neurocrine Biosciences
NBIX
$14.2B
| $78K | ﹤0.01% |
799
-656
| -45% | -$64K |
|
|
KRTX
1188
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $78K | ﹤0.01% |
650
-340
| -34% | -$40.8K |
|
|
FPRX
1189
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $78K | ﹤0.01% |
2,062
+1,164
| +130% | +$44K |
|
1190
BioMarin Pharmaceuticals
BMRN
$10.7B
| $77K | ﹤0.01% |
1,019
-646
| -39% | -$48.8K |
|
1191
FibroGen
FGEN
$49.6M
| $77K | ﹤0.01% |
88
-41
| -32% | -$35.9K |
|
1192
Ironwood Pharmaceuticals
IRWD
$203M
| $77K | ﹤0.01% |
6,889
-2,506
| -27% | -$28K |
|
1193
Madrigal Pharmaceuticals
MDGL
$9.77B
| $77K | ﹤0.01% |
656
-330
| -33% | -$38.7K |
|
1194
MannKind Corp
MNKD
$1.66B
| $77K | ﹤0.01% |
19,748
+9,020
| +84% | +$35.2K |
|
1195
uniQure
QURE
$921M
| $77K | ﹤0.01% |
2,296
+224
| +11% | +$7.51K |
|
|
XLRN
1196
DELISTED
Acceleron Pharma Inc.
XLRN
| $77K | ﹤0.01% |
568
-492
| -46% | -$66.7K |
|
1197
iShares Core MSCI Emerging Markets ETF
IEMG
$106B
| $76K | ﹤0.01% |
+1,185
| New | +$76K |
|
1198
Myriad Genetics
MYGN
$709M
| $76K | ﹤0.01% |
2,510
-396
| -14% | -$12K |
|
1199
Natera
NTRA
$23.8B
| $76K | ﹤0.01% |
744
-618
| -45% | -$63.1K |
|
1200
Syndax Pharmaceuticals
SNDX
$1.41B
| $76K | ﹤0.01% |
3,402
+866
| +34% | +$19.3K |
|